Poloxamer 188 (P188) is a nonionic linear copolymer having an average molecular weight of 8400 Daltons and is also referred to as PLURONIC F68, FLOCOR and RheothRx. The copolymer was approved by the FDA nearly 50 years ago as a therapeutic reagent to reduce viscosity in the blood before transfusions.

The global Poloxamer 188 market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime, Inc. (LPI) ' newest research report, the “Poloxamer 188 Industry Forecast” looks at past sales and reviews total world Poloxamer 188 sales in 2023, providing a comprehensive analysis by region and market sector of projected Poloxamer 188 sales for 2024 through 2030. With Poloxamer 188 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poloxamer 188 industry.

This Insight Report provides a comprehensive analysis of the global Poloxamer 188 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poloxamer 188 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Poloxamer 188 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poloxamer 188 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poloxamer 188.

United States market for Poloxamer 188 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Poloxamer 188 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Poloxamer 188 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Poloxamer 188 players cover:

• BASF
• Croda
• ADEKA
• Hubei Hengshuo Chemical
• Nanjing Well Pharmaceutical

This report presents a comprehensive overview, market shares, and growth opportunities of Poloxamer 188 market by product type, application, key manufacturers and key regions and countries.

1. Segmentation by Type:
• Micronized Poloxamer 188
• Ordinary Poloxamer 188
2. Segmentation by Application:
• Pharmaceutical
• Cosmetic
• Others
3. Market by Region:
• Americas
• APAC
• Europe
• Middle East & Africa

Key Questions Addressed in this Report:

• What is the 10-year outlook for the global Poloxamer 188 market?
• What factors are driving Poloxamer 188 market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Poloxamer 188 market opportunities vary by end market size?
• How does Poloxamer 188 break out by Type, by Application?